Dr. Mehmet Oz is facing a Senate confirmation hearing on Friday, with Democratic senators questioning how he will oversee Medicare and Medicaid as the Trump administration weighs major changes, The New York Times’ Reed Abelson and Susanne Craig report. Republican lawmakers and President Trump are considering severe reductions to health insurance coverage for low-income people and a greater shift toward private plans for older Americans, among other changes. Names in the space include UnitedHealth (UNH), Cigna (CI), Centene (CNC), CVS Health (CVS), Humana (HUM), Moline (MOH), and Elevance Health (ELV).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- CMS rule proposal another challenge for insures, says Wells Fargo
- Vertex non-opioid pain drug picked up by UnitedHealth
- Positive Outlook for UnitedHealth Amid Legal Developments and DOJ’s Weakened Case
- S&P 500 (SPX) Dives as Trump’s Trade War Heats Up
- UnitedHealth wins major finding DOJ’s Medicare fraud lawsuit, Bloomberg says